Cosentyx biosimilar approval is sought by Celltrion in Australia, promising a safe and proven treatment option for patients.
Read MoreCosentyx biosimilar approval is sought by Celltrion in Australia, promising a safe and proven treatment option for patients.
Read MoreAnti-cancer medicine prices are changing across India with 1,364 formulations now updated. Discover the impact on patients and healthcare.
Read MoreAstraZeneca stock analysis reveals key insights for investors looking to navigate market trends and resistance levels effectively.
Read MoreCancer drug price cuts may impact patients relying on PAP programs.
Read MoreSun Pharma eye-care drug production halted due to quality lapses.
Read MoreDrug prices news are crucial for consumers. Discover the latest updates and their impact on healthcare affordability.
Read MoreBone health campaign is targeting 1 lakh patients with proven strategies to improve osteoporosis awareness and treatment.
Read MoreFDA eye disease approval marks a significant milestone for Roche's Enspryng.
Read MoreAchondroplasia drug approval is crucial for patients. Discover how Yuviwel measures against Voxzogo in this important development.
Read MoreDrug price caps are a hot topic. Learn why they focus on cancer medicines and the implications for other medical…
Read More